Succinate, glycerophosphate and ascorbate as sources of cellular energy and as antiteratogens.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000086:Acetazolamide / Q000633:toxicity; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism*; D002642:Chick Embryo; D004357:Drug Synergism; D005994:Glycerophosphates / Q000378:metabolism*; D007328:Insulin / Q000633:toxicity; D008928:Mitochondria / Q000378:metabolism; D009536:Niacinamide / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000037:antagonists & inhibitors; D013386:Succinates / Q000378:metabolism*; D013424:Sulfanilamides / Q000037:antagonists & inhibitors
D005994:Glycerophosphates; D007328:Insulin; D011725:Pyridines; D013386:Succinates; D013424:Sulfanilamides; D009536:Niacinamide; D000086:Acetazolamide; D001205:Ascorbic Acid